{"title":"长期给药纳米硒通过改变海马Tau和促炎细胞因子对与周围神经性疼痛相关的记忆缺陷的潜在影响","authors":"Sepideh Saffarpour , Pargol Sadeghi Tehran , Behnaz Rahimi , Farinaz Nasirinezhad","doi":"10.1016/j.physbeh.2025.114990","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic neuropathic pain is frequently associated with memory disorders linked to hippocampal alteration. Recognizing this co-morbidity could enhance treatment effectiveness. Prior studies have shown that nanoselenium possesses pain-relieving and memory-protecting properties, suggesting its potential in treating neuropathic pain and its associated co-morbidity.</div></div><div><h3>Objective</h3><div>This study aimed to examine the effects of long-term nanoselenium administration on pain-related behaviors and co-morbid memory disorders in rats with chronic constriction injury (CCI) of the sciatic nerve.</div></div><div><h3>Methods</h3><div>The study involved 32 adult male albino Wistar rats, divided into four groups: Control, CCI, CCI+nanoselenium, and CCI+vehicle (<em>n</em> = 8, each group). Nanoselenium or vehicle was administered intraperitoneally for two weeks after CCI surgery. Pain-related behavior was assessed using the acetone test and the Randal-Selitto test, while memory-related behavior was evaluated using a passive avoidance (shuttle-box) test. Additionally, the study involved identifying Tau positive cells through an Immunohistochemistry procedure and measuring IL-1 and TNF levels in the hippocampus using an enzyme-linked immunosorbent assay (ELISA) to explore potential relationships.</div></div><div><h3>Results</h3><div>The data indicated that CCI results in chronic neuropathic pain-related behaviors and memory disorders in rats. Long-term treatment with nanoselenium significantly increased pain threshold (F(1,3)=184.261, <em>P</em> = 0.000), improved memory (F(3,28)=170.726 ,F(3,28)=128.177,F(3,28)=41.552, <em>P</em> = 0.000) and decreased the hippocampal levels of IL-1β (F(3,28)=62.68, <em>P</em> = 0.000), TNFα (F(3,28)=173.12, <em>P</em> = 0.000), and the Tau positive cells/mm³ (F(3,28)=45.26, <em>P</em> = 0.000) in CA1 region in CCI rats.</div></div><div><h3>Conclusion</h3><div>Long-term administration of nanoselenium ameliorated pain-related behavior and improved memory disorder induced by CCI. This effect was associated with altered pro-inflammatory and Tau protein in the rats' hippocampus.</div></div>","PeriodicalId":20201,"journal":{"name":"Physiology & Behavior","volume":"299 ","pages":"Article 114990"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential effects of long-term nanoselenium administration on memory deficits associated with peripheral neuropathic pain through alteration of hippocampal Tau and proinflammatory cytokines\",\"authors\":\"Sepideh Saffarpour , Pargol Sadeghi Tehran , Behnaz Rahimi , Farinaz Nasirinezhad\",\"doi\":\"10.1016/j.physbeh.2025.114990\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Chronic neuropathic pain is frequently associated with memory disorders linked to hippocampal alteration. Recognizing this co-morbidity could enhance treatment effectiveness. Prior studies have shown that nanoselenium possesses pain-relieving and memory-protecting properties, suggesting its potential in treating neuropathic pain and its associated co-morbidity.</div></div><div><h3>Objective</h3><div>This study aimed to examine the effects of long-term nanoselenium administration on pain-related behaviors and co-morbid memory disorders in rats with chronic constriction injury (CCI) of the sciatic nerve.</div></div><div><h3>Methods</h3><div>The study involved 32 adult male albino Wistar rats, divided into four groups: Control, CCI, CCI+nanoselenium, and CCI+vehicle (<em>n</em> = 8, each group). Nanoselenium or vehicle was administered intraperitoneally for two weeks after CCI surgery. Pain-related behavior was assessed using the acetone test and the Randal-Selitto test, while memory-related behavior was evaluated using a passive avoidance (shuttle-box) test. Additionally, the study involved identifying Tau positive cells through an Immunohistochemistry procedure and measuring IL-1 and TNF levels in the hippocampus using an enzyme-linked immunosorbent assay (ELISA) to explore potential relationships.</div></div><div><h3>Results</h3><div>The data indicated that CCI results in chronic neuropathic pain-related behaviors and memory disorders in rats. Long-term treatment with nanoselenium significantly increased pain threshold (F(1,3)=184.261, <em>P</em> = 0.000), improved memory (F(3,28)=170.726 ,F(3,28)=128.177,F(3,28)=41.552, <em>P</em> = 0.000) and decreased the hippocampal levels of IL-1β (F(3,28)=62.68, <em>P</em> = 0.000), TNFα (F(3,28)=173.12, <em>P</em> = 0.000), and the Tau positive cells/mm³ (F(3,28)=45.26, <em>P</em> = 0.000) in CA1 region in CCI rats.</div></div><div><h3>Conclusion</h3><div>Long-term administration of nanoselenium ameliorated pain-related behavior and improved memory disorder induced by CCI. This effect was associated with altered pro-inflammatory and Tau protein in the rats' hippocampus.</div></div>\",\"PeriodicalId\":20201,\"journal\":{\"name\":\"Physiology & Behavior\",\"volume\":\"299 \",\"pages\":\"Article 114990\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physiology & Behavior\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S003193842500191X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BEHAVIORAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physiology & Behavior","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S003193842500191X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
Potential effects of long-term nanoselenium administration on memory deficits associated with peripheral neuropathic pain through alteration of hippocampal Tau and proinflammatory cytokines
Background
Chronic neuropathic pain is frequently associated with memory disorders linked to hippocampal alteration. Recognizing this co-morbidity could enhance treatment effectiveness. Prior studies have shown that nanoselenium possesses pain-relieving and memory-protecting properties, suggesting its potential in treating neuropathic pain and its associated co-morbidity.
Objective
This study aimed to examine the effects of long-term nanoselenium administration on pain-related behaviors and co-morbid memory disorders in rats with chronic constriction injury (CCI) of the sciatic nerve.
Methods
The study involved 32 adult male albino Wistar rats, divided into four groups: Control, CCI, CCI+nanoselenium, and CCI+vehicle (n = 8, each group). Nanoselenium or vehicle was administered intraperitoneally for two weeks after CCI surgery. Pain-related behavior was assessed using the acetone test and the Randal-Selitto test, while memory-related behavior was evaluated using a passive avoidance (shuttle-box) test. Additionally, the study involved identifying Tau positive cells through an Immunohistochemistry procedure and measuring IL-1 and TNF levels in the hippocampus using an enzyme-linked immunosorbent assay (ELISA) to explore potential relationships.
Results
The data indicated that CCI results in chronic neuropathic pain-related behaviors and memory disorders in rats. Long-term treatment with nanoselenium significantly increased pain threshold (F(1,3)=184.261, P = 0.000), improved memory (F(3,28)=170.726 ,F(3,28)=128.177,F(3,28)=41.552, P = 0.000) and decreased the hippocampal levels of IL-1β (F(3,28)=62.68, P = 0.000), TNFα (F(3,28)=173.12, P = 0.000), and the Tau positive cells/mm³ (F(3,28)=45.26, P = 0.000) in CA1 region in CCI rats.
Conclusion
Long-term administration of nanoselenium ameliorated pain-related behavior and improved memory disorder induced by CCI. This effect was associated with altered pro-inflammatory and Tau protein in the rats' hippocampus.
期刊介绍:
Physiology & Behavior is aimed at the causal physiological mechanisms of behavior and its modulation by environmental factors. The journal invites original reports in the broad area of behavioral and cognitive neuroscience, in which at least one variable is physiological and the primary emphasis and theoretical context are behavioral. The range of subjects includes behavioral neuroendocrinology, psychoneuroimmunology, learning and memory, ingestion, social behavior, and studies related to the mechanisms of psychopathology. Contemporary reviews and theoretical articles are welcomed and the Editors invite such proposals from interested authors.